FDA
-
-
-
-
-
-
-
Theralase(R) 1Q2025 Financial Statements
-
-
-
-
-
-
-
Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting
-
-
-
-
-
-
-
Rutherrin(R) Repurposes Non-Cancer Drugs for Cancer Therapy
-
-
-
-
-
-
-
Theralase Release’s 2Q2023 Interim Financial Statements
-
-
-
-
-
-
-
Theralase Releases Q122 Interim Financial Statements
-
-
-
-
-
-
-
Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
-
-
-
-
-
-
-
Canadian Clinical Study Sites Re-Commence Bladder Cancer Study
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

